Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger.
Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business ...
Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to ...
SALT LAKE CITY, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results